Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-56688 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-56688, RRID:AB_2193785
- Product name
- Rabbit Polyclonal Smad7 Antibody
- Antibody type
- Polyclonal
- Description
- Protein G purified.
- Reactivity
- Human, Mouse, Rat, Sheep
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Store at -20C. Avoid freeze-thaw cycles.
Submitted references Retinoic acid induced repair in the lung of adult hyperoxic mice, reducing transforming growth factor-β1 (TGF-β1) mediated abnormal alterations.
Transcriptional induction of salt-inducible kinase 1 by transforming growth factor β leads to negative regulation of type I receptor signaling in cooperation with the Smurf2 ubiquitin ligase.
Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1.
Inhibition of Smad7, a negative regulator of TGF-beta signaling, suppresses autoimmune encephalomyelitis.
Kayalar O, Oztay F
Acta histochemica 2014 Jun;116(5):810-9
Acta histochemica 2014 Jun;116(5):810-9
Transcriptional induction of salt-inducible kinase 1 by transforming growth factor β leads to negative regulation of type I receptor signaling in cooperation with the Smurf2 ubiquitin ligase.
Lönn P, Vanlandewijck M, Raja E, Kowanetz M, Watanabe Y, Kowanetz K, Vasilaki E, Heldin CH, Moustakas A
The Journal of biological chemistry 2012 Apr 13;287(16):12867-78
The Journal of biological chemistry 2012 Apr 13;287(16):12867-78
Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1.
Kidd M, Modlin IM, Pfragner R, Eick GN, Champaneria MC, Chan AK, Camp RL, Mane SM
Cancer 2007 Jun 15;109(12):2420-31
Cancer 2007 Jun 15;109(12):2420-31
Inhibition of Smad7, a negative regulator of TGF-beta signaling, suppresses autoimmune encephalomyelitis.
Kleiter I, Pedré X, Mueller AM, Poeschl P, Couillard-Despres S, Spruss T, Bogdahn U, Giegerich G, Steinbrecher A
Journal of neuroimmunology 2007 Jul;187(1-2):61-73
Journal of neuroimmunology 2007 Jul;187(1-2):61-73
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: Smad7 Antibody - Azide Free [NB100-56688] - Analysis using SMAD7 antibody. Lysate from A549 cells probed with SMAD7 antibody at 5 ug/ml.